Maywood Acquisition Corp.

(Incorporated in the Cayman Islands) We are a newly organized blank check company. Our search for target companies – candidates for an acquisition or a merger, for example – will focus on companies with enterprise values between $200 million and $2 billion with readiness to grow and revenues between $50 million and $500 million. We […]

February 12, 2025 Read More

Northpointe Bancshares Inc.

We are a bank holding company headquartered in Grand Rapids, Michigan, and registered under the Bank Holding Company Act of 1956, as amended (the “BHC Act”). (Incorporated in Michigan)     We operate our business primarily through our wholly-owned banking subsidiary, Northpointe Bank. We emphasize to our employees and clients that our specialized business lines differentiate […]

February 10, 2025 Read More

Aardvark Therapeutics

  We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, including obesity. (Incorporated in Delaware)  We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients. We have focused our efforts on […]

February 7, 2025 Read More

Brag House Holdings, Inc.

Brag House offers an integrated electronic video game sports, or esports, platform designed for casual gamers and their friends to experience the fun, passion, intensity and excitement of college sports rivalries in an organic, inclusive and personalized gaming environment, while creating authentic pathway for brands to connect with our Generation Z (“Gen Z”) audience. The […]

February 6, 2025 Read More

Micropolis Holding Co.

We are a holding company. Micropolis Digital Development FZ-LLC (“Micropolis Dubai”), our wholly owned subsidiary, is a robotics manufacturer founded in 2014 and based in the United Arab Emirates (“UAE”) with its headquarters located in Dubai Production City, Dubai, UAE. (Incorporated in the Cayman Islands) We specialize in developing autonomous mobile robots (“AMRs”) that utilize wheeled electric vehicle (“EV”) […]

Read More

K&F Growth Acquisition Corp. II

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We intend to focus on identifying a business combination target within the experiential entertainment industry across both location-based (in-person) and mobile channels. Select sectors that we intend to target span live events, integrated resorts, family entertainment, casinos, destination hospitality, amusement parks, dining, sports […]

February 4, 2025 Read More

Rithm Acquisition Corp.

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We intend to target the financial services and real estate sectors, which we believe are at a pivotal moment of transformation and will offer compelling investment opportunities for the foreseeable future.   (Note: Rithm Acquisition Corp. priced its SPAC IPO on Feb. […]

Read More

Anbio Biotechnology Limited

(Incorporated in the Cayman Islands)  Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance […]

February 3, 2025 Read More

Copley Acquisition Corp.

(Incorporated in the Cayman Islands)  We are a blank check company. We currently intend to concentrate our efforts on identifying companies in either the technology or lifestyle sectors. We intend to focus our search for a business combination partner in the Asia Pacific (excluding the PRC) and North American regions. Certain of our executive officers and […]

Read More

Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients. (Incorporated in Delaware) An estimated 106,000 people have been diagnosed […]

Read More